Perioperative Management of Pancreatic Cancer w/ Dr. Arsen Osipov & Dr. Daniel Ahn | Ep. 88

Taming Nausea on Claudin 18.2 Therapy

Beyond First-Line Therapy: Strategies for Advanced Neuroendocrine Tumors w/ Dr. Lewis | Ep. 88

Diagnosis & Management of Advanced HER2-Negative Upper GI Cancers w/ Drs. Hsieh & Castillo | Ep. 87

Optimizing Treatment for Advanced HER2-Positive Upper GI Cancers w/ Dr. Buckle & Dr. Hsieh | Ep. 86

Perioperative Management in Upper GI Cancers w/ Dr. Dani Castillo & Dr. Alexandra Gangi | Ep. 85

Managing Refractory MSS-MCRC: Advanced Treatment Strategies w/ Dr. Sahin & Dr. Algaze | Ep. 84

Molecular-Driven Therapies in Colorectal Cancer w/ Dr. Ibrahim Sahin & Dr. Sandra Algaze | Ep. 83

Multidisciplinary Spine Oncology Care: Insights & Techniques w/ Drs. Amsbaugh & Lador | Ep. 22

Bladder Cancer Risk Stratification Best Practices w/ Dr. Patel & Dr. Kristen Scarpato | Ep. 67

Advances in Perioperative Colorectal Cancer Management w/ Dr. Sahin & Dr. Gangi | Tumor Board Ep. 82

CNS Disease in Breast Cancer: Clinical Management & Strategies w/ Dr. Barbara O'Brien | Ep. 81

Personalizing Immunotherapy in MSI-High mCRC: Monotherapy or Combo?

Scaling Community CAR-T: Operational Lessons & Future Directions w/ Dr. Mike Byrne | Ep. 80

Long-Term Outcomes in MSI-High Colorectal Cancer: Lessons from CheckMate-8HW

Gynecologic Cancer Surveillance: Best Practices & Updates w/ Dr. Ritu Salani | Tumor Board Ep. 79

MSI-High Colorectal Cancer: Immunotherapy Wins in CheckMate-8HW

Sequencing Neuroendocrine Tumor Therapies: Personalizing the Next Step

Developing CAR T-cell Programs in Community Oncology w/ Dr. Mike Byrne | Tumor Board Ep. 78

Neuroendocrine Tumors: Weighing PRRT, Surgery & High-Dose SSA

AI's Impact on Oncology Practice w/ Dr. Larry Bilbrey | Tumor Board Ep. 77

Neuroendocrine Tumors: When to Watch, When to Treat

Managing Chemotherapy Intolerance in Gastric & GEJ Cancer

GU Oncology: ASCO Highlights and Impacts on Practice w/ Dr. Alan Tan | BackTable Tumor Board Ep. 76

Modern Approaches to Gastric & GEJ Cancer: Systemic Control vs. Local Therapy

Applying CheckMate 8HW: Practical Updates for MSI-High CRC w/ Dr. Cathy Eng | Ep. 75

Gastric & GEJ Cancer: Perioperative Management Evolution

Systemic Therapy Strategies for Treating Neuroendocrine Tumors w/ Dr. Liao & Dr. Ramirez | Ep. 74

Comprehensive Care in Breast Cancer Survivorship w/ Dr. Lindsay Peterson | Tumor Board Ep. 73

Optimizing Liver-Directed Interventions for Neuroendocrine Tumors w/ Drs. Liao & Khan | Ep. 72

Exploring PARP Inhibitor Combinations in Prostate Cancer w/ Dr. McKay & Dr. Antonarakis | Ep. 71

Metastatic Pancreatic Cancer: Treatment Options & Trials w/ Dr. Dawood Findakly | Tumor Board Ep. 68

Diagnosis & Initial Management of Neuroendocrine Tumors w/ Dr. Liao & Dr. Keutgen | Ep. 70

Managing Intravesical Therapy Toxicities in Bladder Cancer w/ Meredith Donahue & Mary Dunn | Ep. 69

Managing Complications in Pancreatic Cancer w/ Drs. Berman, White & Botta | Tumor Board Ep. 66

Navigating Shared Decision-Making in Bladder Cancer w/ Drs. Bree, Donahue & Ghodoussipour | Ep. 65

Perioperative Management Strategies for Gastric & GE Junction Cancers w/ Dr. Gibson | Ep. 64

Launching Co-Managed APP/MD Clinics for Bladder Cancer w/ Dr. Luckenbaugh & Dr. Donahue | Ep. 63

Radiation Therapy Advances for Gynecologic Cancers w/k Dr. Andrew Lim | Tumor Board Ep. 61

Advancements in Managing Locally Advanced Pancreatic Cancer w/ Dr. White & Dr. Sherer | Ep. 62

PARP Inhibitors: Clinical Trials and Real-World Applications w/ Dr. Agarwal & Dr. Azad | Ep. 60

Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?| Tumor Board Ep. 59

Advanced Hepatocellular Carcinoma: Second-Line Therapy Options w/ Drs. Lockhart & Du | Ep. 58

Growing Radiopharmaceutical Programs: Dosimetry & Clinical Trials

First-Line Therapy for Advanced Hepatocellular Carcinoma w/ Drs. Lockhart & Du | Tumor Board Ep. 57

Launching Radiopharmaceutical Programs: Authorized Users & RAM Licensing

Breast Cancer Precision Medicine: Biomarkers & Treatments w/ Dr. Jessica Jones | Tumor Board Ep. 56

Launching Radiopharmaceutical Programs: Key Barriers & Solutions

Updates in Colorectal Cancer Management: Insights from ASCO GI w/ Dr. Patel | Tumor Board Ep. 55

External Beam Radiation vs Radiopharmaceutical Therapies

Clinical Advances in Muscle Invasive Bladder Cancer w/ Dr. Tyler Stewart | Tumor Board Ep. 54

Hereditary GYN Cancer Syndromes: Practical Screening & Risk‑Reduction Guide w/ Dr. Ciccone | Ep. 53

Radiation Oncology’s Expanding Role in Radiopharmaceuticals

Antibody Drug Conjugates Across the HER2 Spectrum w/ Dr. Sara Nunnery | Tumor Board Ep. 52

Intratumoral Immunotherapy Injections for Melanoma w/ Dr. McQuade & Dr. Sheth | Tumor Board Ep. 51

Integrating Radiopharmaceuticals into Modern Oncology Practice w/ Drs. Boothe & Funk | Ep. 50

Inflammatory Breast Cancer: Symptoms, Diagnosis, & Management w/ Dr. Bora Lim | Tumor Board Ep. 49

BCG Shortage: Salvaging Bladder Cancer Care When Standard Care Is Scarce w/ Dr. Luckenbaugh | Ep. 20

HER2-Positive Metastatic Breast Cancer: Treatment Insights & Protocols w/ Dr. Hamilton | Ep. 48

NSCLC Treatment: Bispecific Antibodies & EGFR Mutations w/ Dr. Wade Iams | Tumor Board Ep. 47